Shanghai Hile Bio-tech (603718) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.001x

Based on the latest financial reports, Shanghai Hile Bio-tech (603718) has a cash flow conversion efficiency ratio of -0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.18 Million ≈ $-173.40K USD) by net assets (CN¥1.70 Billion ≈ $248.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanghai Hile Bio-tech (603718) market capitalisation for the company's overall valuation and market capitalisation.

Shanghai Hile Bio-tech - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Shanghai Hile Bio-tech's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Hile Bio-tech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Hile Bio-tech ranked by their cash flow conversion efficiency. Explore cash flow quality index of Shanghai Hile Bio-tech to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Stove Kraft Limited
NSE:STOVEKRAFT
0.213x
Fabryka Farb i Lakierów ŚNIEŻKA SA
WAR:SKA
0.114x
Jouder Precision Industry Kunshan Co Ltd
SHE:300549
0.044x
Profit Cultural & Creative Group Co Ltd
SHE:300640
-0.018x
Pan Malaysia Holdings Bhd
KLSE:1287
-0.947x
Text S.A.
WAR:TXT
0.303x
Dongsung FineTec Co. Ltd
KQ:033500
-0.011x
Taiga Building Products Ltd.
TO:TBL
-0.173x

Annual Cash Flow Conversion Efficiency for Shanghai Hile Bio-tech (2011–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Hile Bio-tech from 2011 to 2025. View 603718 live share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥895.97 Million
≈ $131.11 Million
CN¥58.83 Million
≈ $8.61 Million
0.066x +140.65%
2024-12-31 CN¥1.70 Billion
≈ $249.23 Million
CN¥46.47 Million
≈ $6.80 Million
0.027x +1190.98%
2023-12-31 CN¥1.17 Billion
≈ $171.91 Million
CN¥-2.94 Million
≈ $-429.95K
-0.003x -100.95%
2022-12-31 CN¥1.11 Billion
≈ $162.57 Million
CN¥292.91 Million
≈ $42.86 Million
0.264x +496.48%
2021-12-31 CN¥987.19 Million
≈ $144.46 Million
CN¥43.63 Million
≈ $6.38 Million
0.044x -74.64%
2020-12-31 CN¥962.20 Million
≈ $140.80 Million
CN¥167.68 Million
≈ $24.54 Million
0.174x +191.93%
2019-12-31 CN¥992.57 Million
≈ $145.24 Million
CN¥59.25 Million
≈ $8.67 Million
0.060x +223.68%
2018-12-31 CN¥1.03 Billion
≈ $150.10 Million
CN¥18.92 Million
≈ $2.77 Million
0.018x -43.23%
2017-12-31 CN¥1.07 Billion
≈ $157.29 Million
CN¥34.92 Million
≈ $5.11 Million
0.032x -69.87%
2016-12-31 CN¥1.01 Billion
≈ $147.11 Million
CN¥108.39 Million
≈ $15.86 Million
0.108x -48.51%
2015-12-31 CN¥963.31 Million
≈ $140.96 Million
CN¥201.69 Million
≈ $29.51 Million
0.209x +6.09%
2014-12-31 CN¥558.50 Million
≈ $81.73 Million
CN¥110.22 Million
≈ $16.13 Million
0.197x -33.07%
2013-12-31 CN¥500.66 Million
≈ $73.26 Million
CN¥147.63 Million
≈ $21.60 Million
0.295x +12.64%
2012-12-31 CN¥467.89 Million
≈ $68.47 Million
CN¥122.48 Million
≈ $17.92 Million
0.262x -29.01%
2011-12-31 CN¥405.74 Million
≈ $59.37 Million
CN¥149.61 Million
≈ $21.89 Million
0.369x --

About Shanghai Hile Bio-tech

SHG:603718 China Biotechnology
Market Cap
$291.55 Million
CN¥1.99 Billion CNY
Market Cap Rank
#15087 Global
#4506 in China
Share Price
CN¥3.07
Change (1 day)
+0.00%
52-Week Range
CN¥2.61 - CN¥7.20
All Time High
CN¥51.09
About

Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The company offers biochemistry reagents, immunoturbidimetric latex reagents, immune turbidimetry reagents, latex enhanced … Read more